AbCellera Biologics Inc (ABCL) has fallen Friday morning, with the stock falling -1.51% in pre-market trading to 20.83. ABCL's short-term technical score of 8 indicates that the stock has traded less bullishly over the last month than 92% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 20% of stocks. AbCellera Biologics Inc has risen 23.97% over the past month, closing at $17.58 on August 27. During this period of time, the stock fell as low as $16.78 and as high as $22.63. ABCL has an average analyst recommendation of Strong Buy. The company has an average price target of $45.25.
ABCL has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on ABCL!